Clinical trial INCB62079-101
A Phase 1, Open-Label, Dose-Escalation and Expansion, Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Incyte Corporate |
| EudraCT Identifier | 2017-001153-13 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03144661 |
| Inclusion criteria | after standard therapy |
| Last update |